PMD psychemedics.com: Quick Liquidity

Psychemedics business protection is built on exclusive patents and strict FDA control, which is confirmed by the valuation trend on GURU.Markets, where the indicator stands at 1.29. Psychemedics relies on hair tests recognized as benchmarks for the corporate sector. In its maturity stage, the company is betting on the legal significance and flawless accuracy of its niche diagnostic services.

Investors assess the operational strength of assets through a company's ability to instantaneously settle its obligations. This is critical for Psychemedics (PMD), as testing volumes depend on corporate hiring cycles. The quick liquidity reflected on this chart excludes slowly realizable inventories, accounting only for cash and accounts receivable. A stable level of this metric confirms the business's resilience to macro shocks due to mandatory industry standards.